Study * (ACCESS) A Case Controlled Etiologic Study of Sarcoidosis (ACCESS) (ACCORD) Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ARDSNet-ALTA) Acute Respiratory Distress Network (ARDSNet) Studies 06 and 08 Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol Versus Placebo for the Treatment of Acute Lung Injury (ALTA) (ARDSNet-ALVEOLI) Acute Respiratory Distress Network (ARDSNet) Study 04 Assessment of Low tidal Volume and elevated End-expiratory volume to Obviate Lung Injury (ALVEOLI) (ARDSNet-ARMA/KARMA/LARMA) Acute Respiratory Distress Network (ARDSNet) Studies 01 and 03 Lower versus higher tidal volume, ketoconazole treatment and lisofylline treatment (ARMA/KARMA/LARMA) (ARDSNet-EDEN) Acute Respiratory Distress Network (ARDSNet) Studies 07, 08, 09, 11, and 12 Early Versus Delayed Enteral Feeding to Treat People with Acute Lung Injury or Acute Respiratory Distress Syndrome (EDEN) (ARDSNet-FACTT) Acute Respiratory Distress Network (ARDSNet) Study 05 Fluid and Catheter Treatment Trial (FACTT) (ARDSNet-LASRS) Acute Respiratory Distress Network (ARDSNet) Study 02 Late Steroid Rescue Study (LaSRS) (ARDSNet-Omega) Acute Respiratory Distress Network (ARDSNet) Studies 07 and 08 Prospective, Randomized, Blinded, Placebo-controlled, Multi-center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury or Acute Respiratory Distress Syndrome (Omega) (ARDSNet-SAILS) Acute Respiratory Distress Network (ARDSNet) Studies 10 and 12 Statins for Acutely Injured Lungs from Sepsis (SAILS) (AsthmaNet-ALFA) AsthmaNet Proof of Concept Study of Alendronate for Asthma (ALFA) (AsthmaNet-APRIL/OCELOT) AsthmaNet Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children (APRIL) and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children (OCELOT) (AsthmaNet-BARD) AsthmaNet Best African American Response to Asthma Drugs (BARD) (AsthmaNet-INFANT/AVICA) AsthmaNet Individualized Therapy For Asthma in Toddlers (INFANT) and Acetaminophen Versus Ibuprofen in Children With Asthma (AVICA) (AsthmaNet-Microbiome) AsthmaNet Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment (AsthmaNet-SIENA) AsthmaNet Steroids in Eosinophil Negative Asthma (SIENA) (AsthmaNet-STICS) AsthmaNet Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) (AsthmaNet-VIDA) AsthmaNet Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) (BABY HUG) Hydroxyurea to Prevent Organ Damage in Children with Sickle Cell Anemia (BABY HUG) Phase III Clinical Trial and Follow-Up Observational Studies I and II (BMT CTN-0102) Blood and Marrow Clinical Trials Network (BMT CTN) A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy Versus Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (0102) (BMT CTN-0201) Blood and Marrow Clinical Trials Network (BMT CTN) Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers (0201) (BMT CTN-0402) Blood and Marrow Clinical Trials Network (BMT CTN) A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (0402) (CBB) NHLBI Umbilical Cord Blood Unit Collection (CBB) (COAG) Clarification of Optimal Anticoagulation Through Genetics (COAG) (COBLT) Cord Blood Transplantation Study (COBLT) (CSSCD) Cooperative Study of Sickle Cell Disease (CSSCD) (CureSCi-SCBank) Cure Sickle Cell Initiative (CureSCi) - Sickle Cell Hematopoietic Stem Cell Bank (SCBank) (DASH) Dietary Approaches to Stop Hypertension (DASH) (DASH-Sodium) Dietary Approaches to Stop Hypertension - Sodium Study (DASH-Sodium) (DISC) Dietary Intervention Study in Children (DISC) (DISC06) Dietary Intervention Study in Children Follow-Up Study (DISC06) (GenTAC) National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) (HEIRS) Hemochromatosis and Iron Overload Screening Study (HEIRS) (HHP) Honolulu Heart Program (HHP) (LHMP) The Lung HIV Microbiome Project (LHMP) (LTRC) Lung Tissue Research Consortium (LTRC) (MHCS) Multicenter Hemophilia Cohort Studies (MHCS) (MSH) Multicenter Study of Hydroxyurea (MSH) (NANB-TAH) Natural History Study of Non-A, Non-B Post-Transfusion Hepatitis (NANB-TAH) (NGHS) NHLBI Growth and Health Study (NGHS) (OMNI Heart) Optimal Macronutrient Intake Trial to Prevent Heart Disease (OMNI Heart) (P2C2) Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) (PACTG) Anti-HIV Immunoglobulin in Prevention of Maternal-Fetal HIV Transmission: Pediatric AIDS Clinical Trials Group protocol 185 (PACTG) (PEACE) Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE) (PETAL-CLOVERS) Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) (PETAL-ROSE) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) (PETAL-VIOLET) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET) (PREMIER) PREMIER: Lifestyle Interventions for Blood Pressure Control (PREMIER) (REDS II-LAPS) Retrovirus Epidemiology Donor Study-II (REDS II) Leukocyte Antibodies Prevalence Study (LAPS) (REDS II-RISE) Retrovirus Epidemiology Donor Study-II (REDS II) Donor Iron Status Evaluation Study (RISE) (REDS-GLPR) Retrovirus Epidemiology Donor Study (REDS) General Leukocyte/Plasma Repository (GLPR) (REDS-RADAR) Retrovirus Epidemiology Donor Study (REDS) Allogeneic Donor and Recipient Repository (RADAR) (SPIROMICS) Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) (SPRINT) Systolic Blood Pressure Intervention Trial (SPRINT) (TIMI II) Thrombolysis in Myocardial Ischemia Trial II (TIMI II) (TOPCAT) Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) (TSS) Transfusion Safety Study (TSS) (TTVS) Transfusion-Transmitted Viruses Study (TTVS) (VA2-TAH) VA Cooperative Study of the Efficacy of Hepatitis Immune Serum Globulin for the Prevention or Modification of Post-Transfusion Hepatitis (VA2-TAH) (WLM) Weight Loss Maintenance (WLM) (WNV) West Nile Virus Study (WNV) (generic) Other (generic)
Resources from multiple studies may be requested via one request form using the above drop down menu.
Describe this request, including a summary of the rationale, main hypothesis and proposed research aims *
A brief overview of your research needs.
Describe any additional requirements pertaining to the biospecimens themselves, such as anticoagulant used, additives, preservatives, etc.
Describe the characteristics of the subjects to be searched for available specimens. Criteria might include gender, age, disease status, genotype, etc. Be as specific as possible.
Requested study visit(s), if applicable
Only applicable for studies that have more than one specimen draw point. If any visit is acceptable, please indicate so. Refer to the "Available Biospecimens" tables on each study description page for more information regarding the available visits for each material type. If more than one visit is requested, please indicate if you can accept subjects that have specimens available from at least one, but not all of the requested visits.
Analyte(s) or parameter(s) to be tested *
Describe the assay(s) to be performed and include any test volume requirements.
Type of assay(s)/ platform(s) to be used *
Describe the assay kit(s)/platform(s) to be used, if applicable.
Rationale for number of biospecimens requested, including power calculations, and describe the use of covariates, if applicable *
Also describe your intended use of covariates from study datasets, if applicable.
Will the results be used for a commercial purpose?
Original Study Investigator? *
Were you an investigator with the original (parent) study(ies) referenced in this request?